KYORIN Holdings, Inc. (4569.T)
JPY 1486.0
(0.75%)
JPY 1486.0
(0.75%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 51.4 Billion JPY | 2.46% |
| 2022 | 50.16 Billion JPY | 1.47% |
| 2021 | 49.44 Billion JPY | -4.24% |
| 2020 | 51.62 Billion JPY | -9.48% |
| 2019 | 57.03 Billion JPY | -0.66% |
| 2018 | 57.41 Billion JPY | -6.77% |
| 2017 | 61.57 Billion JPY | -4.57% |
| 2016 | 64.52 Billion JPY | -10.53% |
| 2015 | 72.12 Billion JPY | 8.42% |
| 2014 | 66.52 Billion JPY | -2.68% |
| 2013 | 68.35 Billion JPY | 2.17% |
| 2012 | 66.89 Billion JPY | 0.89% |
| 2011 | 66.3 Billion JPY | -0.31% |
| 2010 | 66.51 Billion JPY | 6.79% |
| 2009 | 62.28 Billion JPY | 15.14% |
| 2008 | 54.09 Billion JPY | 9.7% |
| 2007 | 49.31 Billion JPY | 6.11% |
| 2006 | 46.47 Billion JPY | -2.24% |
| 2005 | 47.53 Billion JPY | 9.0% |
| 2004 | 43.61 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 12.35 Billion JPY | -5.65% |
| 2023 Q1 | 12.23 Billion JPY | -6.71% |
| 2023 Q4 | 13.09 Billion JPY | -10.74% |
| 2023 FY | 51.4 Billion JPY | 2.46% |
| 2023 Q3 | 14.66 Billion JPY | 28.52% |
| 2023 Q2 | 11.41 Billion JPY | -6.71% |
| 2022 Q3 | 15.44 Billion JPY | 46.06% |
| 2022 Q4 | 13.11 Billion JPY | -15.09% |
| 2022 Q1 | 11.03 Billion JPY | -16.38% |
| 2022 Q2 | 10.57 Billion JPY | -4.22% |
| 2022 FY | 50.16 Billion JPY | 1.47% |
| 2021 Q2 | 11.35 Billion JPY | 3.12% |
| 2021 FY | 49.44 Billion JPY | -4.24% |
| 2021 Q3 | 13.87 Billion JPY | 22.13% |
| 2021 Q4 | 13.2 Billion JPY | -4.82% |
| 2021 Q1 | 11.01 Billion JPY | -14.16% |
| 2020 Q1 | 13.09 Billion JPY | -17.75% |
| 2020 Q4 | 12.82 Billion JPY | -8.21% |
| 2020 Q2 | 11.72 Billion JPY | -10.43% |
| 2020 Q3 | 13.97 Billion JPY | 19.18% |
| 2020 FY | 51.62 Billion JPY | -9.48% |
| 2019 Q4 | 15.91 Billion JPY | -3.9% |
| 2019 Q1 | 13.32 Billion JPY | -8.46% |
| 2019 Q2 | 11.22 Billion JPY | -15.78% |
| 2019 Q3 | 16.56 Billion JPY | 47.6% |
| 2019 FY | 57.03 Billion JPY | -0.66% |
| 2018 Q1 | 13.15 Billion JPY | -12.72% |
| 2018 Q4 | 14.55 Billion JPY | -10.41% |
| 2018 Q2 | 13.44 Billion JPY | 2.16% |
| 2018 Q3 | 16.25 Billion JPY | 20.88% |
| 2018 FY | 57.41 Billion JPY | -6.77% |
| 2017 Q1 | 14.56 Billion JPY | -8.78% |
| 2017 Q4 | 15.07 Billion JPY | -20.11% |
| 2017 Q3 | 18.87 Billion JPY | 44.38% |
| 2017 Q2 | 13.07 Billion JPY | -10.23% |
| 2017 FY | 61.57 Billion JPY | -4.57% |
| 2016 Q1 | 16.06 Billion JPY | -9.88% |
| 2016 FY | 64.52 Billion JPY | -10.53% |
| 2016 Q3 | 17.76 Billion JPY | 20.56% |
| 2016 Q4 | 15.96 Billion JPY | -10.16% |
| 2016 Q2 | 14.73 Billion JPY | -8.24% |
| 2015 FY | 72.12 Billion JPY | 8.42% |
| 2015 Q3 | 23.47 Billion JPY | 54.77% |
| 2015 Q2 | 15.16 Billion JPY | -3.11% |
| 2015 Q1 | 15.65 Billion JPY | -11.32% |
| 2015 Q4 | 17.82 Billion JPY | -24.09% |
| 2014 FY | 66.52 Billion JPY | -2.68% |
| 2014 Q2 | 14.23 Billion JPY | -8.34% |
| 2014 Q3 | 19.09 Billion JPY | 34.12% |
| 2014 Q4 | 17.65 Billion JPY | -7.55% |
| 2014 Q1 | 15.53 Billion JPY | -6.85% |
| 2013 Q3 | 19.92 Billion JPY | 32.19% |
| 2013 Q4 | 16.67 Billion JPY | -16.3% |
| 2013 Q2 | 15.07 Billion JPY | -9.65% |
| 2013 Q1 | 16.68 Billion JPY | -3.17% |
| 2013 FY | 68.35 Billion JPY | 2.17% |
| 2012 Q1 | 15.84 Billion JPY | -2.95% |
| 2012 FY | 66.89 Billion JPY | 0.89% |
| 2012 Q4 | 17.22 Billion JPY | -13.02% |
| 2012 Q3 | 19.8 Billion JPY | 41.29% |
| 2012 Q2 | 14.01 Billion JPY | -11.51% |
| 2011 FY | 66.3 Billion JPY | -0.31% |
| 2011 Q2 | 13.24 Billion JPY | -19.89% |
| 2011 Q3 | 20.2 Billion JPY | 52.57% |
| 2011 Q4 | 16.32 Billion JPY | -19.21% |
| 2011 Q1 | 16.53 Billion JPY | -10.16% |
| 2010 Q2 | 14.14 Billion JPY | -8.68% |
| 2010 Q1 | 15.48 Billion JPY | 2.34% |
| 2010 FY | 66.51 Billion JPY | 6.79% |
| 2010 Q4 | 18.4 Billion JPY | -0.47% |
| 2010 Q3 | 18.48 Billion JPY | 30.76% |
| 2009 FY | 62.28 Billion JPY | 15.14% |
| 2009 Q2 | 14.06 Billion JPY | -3.81% |
| 2009 Q3 | 18.47 Billion JPY | 31.41% |
| 2009 Q4 | 15.13 Billion JPY | -18.11% |
| 2009 Q1 | 14.61 Billion JPY | -5.51% |
| 2008 FY | 54.09 Billion JPY | 9.7% |
| 2008 Q3 | 16.08 Billion JPY | 49.29% |
| 2008 Q4 | 15.47 Billion JPY | -3.83% |
| 2008 Q2 | 10.77 Billion JPY | 0.0% |
| 2007 FY | 49.31 Billion JPY | 6.11% |
| 2006 FY | 46.47 Billion JPY | -2.24% |
| 2005 FY | 47.53 Billion JPY | 9.0% |
| 2004 FY | 43.61 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -5.432% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 97.648% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 72.657% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 86.074% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -1351.63% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 47.02% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -34.478% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 91.235% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -756.952% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 34.913% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 1.287% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -280.262% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -564.254% |
| Tsumura & Co. | 68.81 Billion JPY | 25.309% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -37.65% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -107.325% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 36.842% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -211.232% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | -2.429% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -4663.67% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -422.411% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -1065.265% |
| MedRx Co., Ltd | 26 Million JPY | -197592.308% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -540.441% |
| Solasia Pharma K.K. | 337 Million JPY | -15152.226% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 7031563.748% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -67.618% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 5.374% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -136080.585% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 54.507% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -674.143% |